MN-ECOLAB-INC
Ecolab, a global sustainability leader offering water solutions and services, today announced findings from the inaugural Ecolab Watermark™ Study. The global consumer research examined the state of water stewardship through water’s importance, usage, connection to climate and responsibility among key consumer populations around the world.
By 2030, the planet is set to face a 56% water deficit, according to the World Resources Institute, and 1.6 billion people will lack safely managed drinking water, according to the United Nations. It’s amid this pressing water crisis that Ecolab developed the Ecolab Watermark Study to identify trends, help educate and generate action across industry stakeholders, specifically those in Asia/Pacific, China, Europe, India/Middle East/Africa (IMEA), Latin America and the United States (U.S.).
Among its global findings, the Ecolab Watermark Study uncovered several critical water-related trends:
- Access to clean and safe water is a paramount concern for consumers in every region. Latin America (92%), China (85%) and the U.S. (81%) have the highest percentage of consumers who are more concerned about access to clean and safe water than other climate-related issues, such as pollution or climate change.
- Consumers hold governments and businesses most responsible for water conservation. However, consumers do not believe these leaders care enough about their impact on water or climate change. This was most pronounced in the U.S., Europe, Latin America and Asia/Pacific, where between 42% and 46% of people believed their leaders cared.
- Consumers believe that industry has no clear plan to address water scarcity, despite the perceived responsibility and importance. This concern is most evident in China (82%), Latin America (78%), and IMEA (78%), but also noticeably visible in Europe (66%), the U.S. (65%) and Asia/Pacific (60%).
“The water crisis impacts communities regardless of location and is often overlooked in the global response to climate change. As we continue our work to transform the way the world thinks about water, the results from the Ecolab Watermark Study should galvanize leaders to assume a larger role in protecting this precious and finite resource,” said Christophe Beck, chairman and chief executive officer, Ecolab. “Time is running out to address this challenge, and consumers across the world are saying that businesses must act now. The good news for industry is that meeting this responsibility can deliver positive sustainability and business outcomes.”
In response to the perceived lack of accountability, consumers are themselves adopting environmentally friendly buying behaviors. According to the study, consumers are willing to stop purchasing products that require a significant amount of water to produce, as well as pay more for goods that are made using sustainable business practices, particularly in IMEA (88%), China (85%) and Latin America (81%).
Despite the known challenges, consumers remain optimistic that the water crisis can be mitigated with proper and immediate action. On average, three out of four consumers across the globe believe that water scarcity can be effectively addressed, according to the study, with the optimism most evident in Latin America (84%), IMEA (83%) and China (78%).
“If industry is not at the table to advocate and develop climate and water solutions that protect our communities, we will continue to fuel consumer sentiment that we’re not doing enough,” said Emilio Tenuta, senior vice president and chief sustainability officer, Ecolab. “By focusing solely on water and consumer perceptions of the ongoing crisis, the Ecolab Watermark Study provides unique insights on where and how stakeholders—whether its government, businesses, NGOs or even individuals—can work together to successfully address critical global challenges.”
In addition to offering global and regional findings, the Ecolab Watermark Study includes data for 15 individual countries. The U.S.-specific data showed that 81% of consumers are concerned about access to clean and safe water, and they consider businesses and governments to have the highest level of responsibility when it comes to funding for water conservation. Plus, 65% of U.S. consumers agree that businesses and manufacturers lack clear guidance and plans to combat water scarcity. Lastly, even though less than half of U.S. consumers believe that business and government leaders care about climate change or water conservation, 70% remain optimistic that water scarcity can be effectively addressed.
The Ecolab Watermark Study was conducted in partnership with Morning Consult in 2023 among a sample of general population adults. Ecolab will update and release new editions of its Ecolab Watermark Study annually. For detailed results, including an interactive dashboard, visit watermark.ecolab.com.
About Ecolab
A trusted partner for millions of customers, Ecolab (NYSE:ECL) is a global sustainability leader offering water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. Building on a century of innovation, Ecolab has annual sales of $14 billion, employs more than 47,000 associates and operates in more than 170 countries around the world. The company delivers comprehensive science-based solutions, data-driven insights and world-class service to advance food safety, maintain clean and safe environments, and optimize water and energy use. Ecolab’s innovative solutions improve operational efficiencies and sustainability for customers in the food, healthcare, life sciences, hospitality and industrial markets. www.ecolab.com
Follow us on LinkedIn @Ecolab, Twitter @Ecolab, Instagram @Ecolab_Inc and Facebook @Ecolab.
About the Ecolab Watermark™ Study
Launched in 2023, the Ecolab Watermark Study is annual research conducted by Ecolab. The global study reports on the state of water stewardship by measuring water’s importance, usage, connection to climate and responsibility among key consumer populations. This research was conducted between February 15 – March 3, 2023, among a sample of general population adults. The interviews were conducted online. Results from the full study have a margin of error of plus or minus 2–3 percentage points. Some geographies may be weighted with fewer variables depending on local census data availability.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230918273418/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Sai Life Sciences Opens Dedicated Facility for Veterinary APIs in Bidar, India18.9.2025 18:22:00 CEST | Press release
Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the opening of Unit VI, a dedicated facility for Veterinary Active Pharmaceutical Ingredient (API) production, in Bidar, India. Located alongside Unit IV, the company’s flagship API manufacturing site, Unit VI has been established exclusively for veterinary APIs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918612071/en/ Sai Life Sciences’ Veterinary APIs Unit in Bidar, India. The new facility is designed to meet the highest standards of safety, sustainability, and regulatory compliance, ensuring the production of high-quality APIs for veterinary applications. With this expansion, Sai Life Sciences aims to provide efficient and scalable manufacturing solutions to leading global animal health companies. Making the announcement, Krishna Kanumuri, CEO & Managing Direct
Celltrion Announces Commercial Availability of Omlyclo™ Across Europe at EADV 202518.9.2025 17:45:00 CEST | Press release
Celltrion’s Omlyclo™, the first and only omalizumab biosimilar in Europe, will be commercially available starting in Norway, with subsequent rollouts in European countries Results from the global Phase III clinical trial of Omlyclo™ (CT-P39) for the treatment of chronic spontaneous urticaria (CSU), allergic asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) will be presented at a satellite symposium during the 2025 European Academy of Dermatology and Venereology (EADV) Congress Celltrion highlights the strength of its expanding dermatology portfolio with positive clinical results for CT-P55, a biosimilar candidate referencing secukinumab With the launch of Omlyclo™, Celltrion underscores its commitment to advancing innovative and accessible treatments in immunology and dermatology Celltrion, Inc. today showcased its longstanding commitment to expanding its biosimilar portfolio in the field of immuno-dermatology by attending the 2025 European Academy of Dermatology and Venereo
Andersen Consulting tilføjer samarbejdsfirmaet Charter18.9.2025 17:14:00 CEST | Pressemeddelelse
Andersen Consulting udvider sine digitale transformationskapaciteter gennem en samarbejdsaftale med Charter, et canadisk konsulentfirma, der er specialiseret i IT-strategi, managed services og applikationslevering. Charter blev grundlagt i 1997 og leverer teknologiprojekter med en forretningsorienteret tankegang og dyb teknisk ekspertise, herunder inden for IT-rådgivning, cloud-infrastruktur, cybersikkerhed, applikationsudvikling, projektlevering og forretningsarkitektur. Charter hjælper traditionelle virksomheder, offentlige institutioner, tjenesteudbydere og mellemstore kunder med implementering, netværksinfrastruktur og kundeorienterede applikationer – der leveres gennem en livscyklus-tilgang fra strategi til udførelse. "Vores mål hos Charter har altid været at fjerne kompleksiteten fra IT og hjælpe organisationer med at bevæge sig fremad med tillid," siger Kelly Michell, præsident for Charter. "Vores samarbejde med Andersen Consulting gør det muligt for os at bringe vores integrere
Andersen Consulting udvider sit udbud inden for cybersikkerhed og teknologi med tilføjelsen af Move18.9.2025 17:06:00 CEST | Pressemeddelelse
Andersen Consulting har indgået en samarbejdsaftale med Move, der er en førende virksomhed inden for it-infrastruktur, driftstjenester og digitale løsninger til virksomheder. Move befinder sig i Norge og Sverige. Move blev grundlagt i 1989 og leverer konsulentydelser, it-løsninger og driftstjenester. Virksomheden har ekspertise inden for cybersikkerhed, cloud-løsninger, server- og lagringsløsninger, netværkskommunikation og implementering af AI. Move samarbejder med mellemstore og store virksomheder om at designe, implementere og drive sikre, skalerbare og fremtidssikrede it-miljøer. "Dette samarbejde er en spændende mulighed for at skabe endnu større værdi for vores kunder," siger Roald Sannæs, der er administrerende direktør i Move. "Med vores kompetencer og Andersen Consultings globale rækkevidde og ekspertise kan vi levere mere helhedsorienterede løsninger, der hjælper organisationer med at løse nutidens udfordringer og forudse fremtidens muligheder." "Move har opbygget et godt ren
Setting the Standard: AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’18.9.2025 16:40:00 CEST | Press release
The inaugural ranking by TIME, in partnership with Statista, features AMRA as one of the world’s leading health technology companies that are “driving innovation, enhancing accessibility, and contributing to a more effective and sustainable health care system” AMRA Medical is proud to share its inclusion in the World’s Top HealthTech Companies list, published today by TIME in collaboration with Statista. This recognition positions AMRA among an elite group of global innovators that are leading healthcare transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918372780/en/ AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’ The selection, which comes just one week after celebrating AMRA’s 15 years of progress and innovation within the body composition space, highlights AMRA’s long-standing commitment to becoming a global leader in health informatics. By delivering detailed, reproduc
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom